Human papillomavirus and disease mechanisms: Relevance to oral and cervical cancers

Oral Diseases

Volumn 11, Issue 6, 2005, Pages 350-359

  Nair, S ^a   Pillai, M Radhakrishna ^b  

^a REGIONAL CANCER CENTRE   (India)

^b RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

HPV; MTHFR; NF B; Nutrigenomics; Polymorphism; Variants

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN E6; PROTEIN P53; TRANSCRIPTION FACTOR; XENOBIOTIC AGENT;

DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE INTERACTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MOUTH CANCER; NUTRIGENOMICS; NUTRITION; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS ONCOGENE; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MOUTH NEOPLASMS; NF-KAPPA B; ONCOGENES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 28444431942     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2005.01127.x     Document Type: Review

References (122)

1. Aggelopoulou E, Troungos C, Goutas N et al (1998). Immunohistochemical detection of p53 protein in HPV positive oral lesions. Anticancer Res 18: 4511-4515.
2. Anderson JA, Irish JC, McCachlin CM et al (1994). H-ras ongogene mutation and human papillomavirus infection in oral carcinomas. Arch Otolaryngol Head Neck Surg 120: 755-760.
3. Andl T, Kahn T, Pfuhl A et al (1998). Etiological involvment of oncogenic HPV in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58: 5-13.
4. Antony AC (1992). The biological chemistry of folate receptors. Blood 79: 2807-2820.
5. Antony AC (1996). Folate receptors. Annu Rev Nutr 16: 501-521.
6. Antony AC, Tang YS, Khan R et al (2004). Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogenous nuclear ribonucleoprotein E1 interactions. J Clin Invest 113: 285-301.
7. Atalah E, Ueteaga C, Rebolledo A et al (2001). Diet, smoking and reproductive history as risk factor for cervical cancer. Rev Med Chil 129: 597-603.
8. Autrup H (2000). Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutation Res 464: 65-76.
9. Balaram P, Nalinakumari KR, Abraham E et al (1995). Human papillomaviruses in 91 oral cancers from Indian betel quid chewers-high prevalence and multiplicity of infections. Int J Cancer 61: 450-454.
10. Baldwin AS (2001). Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 107: 241-246.
11. Baldwin AS Jr, Azizkhan JC, Jensen DE et al (1991). Induction of NF-κB DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts. Mol Cell Biol 11: 4943-4951.
12. Beg AA, Baltimore D (1996). An essential role for NF-κB in preventing TNF-alpha-induced cell death. Science 274: 782-784.
13. Bustos DA, Pavan JV, Carricart SE et al (1999). Human papillomavirus detection in oral cancer lesions in the city of Cordoba. Rev Fac Cien Med Univ Nac Cordoba 56: 65-71.
14. Cabannes E, Khan G, Aillet F et al (1999). Mutations in the IκBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα. Oncogene 18: 3063-3070.
15. Caporaso N, Goldstein A (1995). Cancer genes: single and susceptibility-exposing the difference. Pharmacogenetics 5: 59-63.
16. Carmel R, Green R, Rosenblatt DS et al (2003). Update on cobalamin, folate, and homocysteine. Hematology (Am Soc Hematol Educ Program) 2003: 62-81.
17. Chakrabarti O, Veeraraghavulu K, Tergaonkar V et al (2004). Human papillomavirus type16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by Notch signaling and oncogenic Ras. J Virol 78: 5934-5945.
18. Chen C, Nirunsuksiri W (1999). Decreased expression of glutathione s-transferase Ml in HPV16-transfected human cervical keratinocytes in culture. Carcinogenesis 20-4: 699-703.
19. Chen Z, Storthz KA, Shllitoe EJ (1997). Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences. Cancer Res 57: 1614-1619.
20. Chen S, Fibley A, Wang CY (2002) Potentiation of TNF-mediated apoptosis of oral squamous cell carcinoma cells by adenovirus-mediated gene transfer of NFκB inhibitor. J Dent Res 81: 98-102.
21. Chu ZL, McKinsey TA, Liu L et al (1997). Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis C-IAP2 is under NF-κB control. Proc Natl Acad Sci U S A 94: 10057-10062.
22. Cusack JC Jr, Liu R, Houston M et al (2001). Enhanced chemosensitivity to CPT-11 with Proteasome Inhibitor PS-341: Implications for systemic Nuclear Factor-κB inhibition. Cancer Res 61: 3535-3540.
23. Du J, Chen GG, Vlantis AC et al. (2003). The nuclear localization of NFκB and P53 is positively correlated with HPV16 E 7 level in laryngeal squamous cell carcinoma. J Histochem Cytochem 59: 533-539.
24. Duffey DC, Chen Z, Dong G et al (1999). Expression of a dominant negative mutant Inhibitor-κBα of NFκB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression and tumor growth in vivo. Cancer Res 59: 3468-3474.
25. Dyson N, Howley PM, Munger K et al (1989). The HPV16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 242: 934-937.
26. Fontaine V, van der Meijden E, de Graaf J et al (2000). A functional NFκB binding site in the human papilloma virus type 16 long control region. Virology 272: 40-49.
27. Franceschi S, Munoz N, Snijders PJ (2000). How strong and how wide is the link between HPV and oropharyngial cancer? Lancet 356: 871-872.
28. Gerhard DS, Nguyen LT, Zhang ZY et al (2003). A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer. Gynecol Oncol 90: 560-565.
29. Gillison ML, Koch WM, Capone RB et al (2000). Evidence for a causal association between HPV and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720.
30. Gilmore TD (1992). Role of rel family genes in normal and malignant lymphoid cell growth. Cancer Surv 15: 69-87.
31. Ginnoudis A, Herrington CS (2001). Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193: 295-302.
32. Gonzalez FJ, Idle JR (1994). Pharmacogenetic phenotyping and genotyping. Present status and future potential. Clin Pharmacokinet 26: 59-70.
33. Gonzalez Losa MR, Teran MLM, Puerto-Solis M et al (2004). Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J Clin Virol 29: 95-98.
34. Goodman MT, McDuffie K, Hernandez B et al (2001a). CYP1A1, GSTM1 and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol 81: 263-269.
35. Goodman MT, McDuffie K, Hernandez B et al (2001b). Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 10: 1275-1280.
36. Guo WD, Hsing AW, Li JY et al (1994). Correlation of cervical cancer mortality with reproductive and dietary factors, and serum markers in China. Int J Epidemiol 23: 1127-1132.
37. Havard L, Delvenne P, Frare P et al (2002). Differential production of cytokines and activation of NFκB in HPV-transformed keratinocytes. Virology 298: 271-285.
38. Hayes JD, Pulford DJ (1995). The glutathione s-transferase supergene Family Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600.
39. Heinzel PA, Balaram P, Bernard HU (1996). Mutations and polymorphisms in the p53, p21, p16 genes in oral carcinomas of Indian betel quid chewers. Int J Cancer 68: 420-423.
40. Hiscott J, Kwon H, Genin P (2001). Hostile takeovers: viral appropriation of the NF-κB pathway. J Clin Invest 107: 143-151.
41. Hoffmann M, Kahn T, Mahnke CG et al (1998). Prevalence of human papilloma virus in squamous cell carcinoma of the head and neck determined by polymerase chain reaction and Southern blot hybridization: proposal for optimized diagnostic requirements. Acta Otolaryngol (Stockh) 118: 138-144.
42. Hoffmann M, Lohrey C, Hunziker A et al (2004). Human papilloma virus type 16 E6 and E7 genotypes in head-and-neck carcinomas. Oral Oncol 40: 520-524.
43. Jayant K, Notani M (1991). Epidemiology of oral cancer. In: Rao RS, Desai PB, Eds. Oral Cancer. Professional Education Division: Tata Memorial Hospital: Bombay, pp. 1-7.
44. Jayant K, Rao RS, Nene BM (1995). Improved stage at diagnosis of cervical cancer with increased cancer awareness in a rural Indian population. Int J Cancer 63: 161-163.
45. Jeon S, Lambert PF (1995). Integration of human papilloma-virus type 16 DNA into human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 92: 1654-1658.
46. Kammer C, Tommasino M, Syrjanen S et al (2002). Variants of the long control region and the E6 ongogene in European human papilloma virus type 16 isolates: implications for cervical disease. Br J Cancer 86: 269-273.
47. Karin M, Cao Y, Greten FR et al (2002). NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301-310.
48. Katiyar S, Thelma BK, Murthy NS et al (2003). Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18- associated cervical and oral cancer in India. Mol Cell Biochem 252: 117-124.
49. Ke LD, Adler-Storthz K, Mitchell MF et al (1999). Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines. Oral Oncol 35: 415-420.
50. Kim JW, Lee CG, Park YG et al (2000). Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer 88: 2082-2091.
51. Klussmann JP, Weissenborn SJ, Wieland U et al (2001). Prevalence, distribution and viral load of human papilloma virus 16 DNA in tonsillar carcinomas. Cancer 92: 2875-2884.
52. Kolonel LN, Hankin JH, Lee J et al (1981). Nutrient intakes in relation to cancer incidence in Hawaii. Br J Cancer 44: 332-339.
53. Lakshmi S, Nair AS, Pillai MR (1993). Oral cancer and human papilloma viruses: is there a link? .J Surg Oncol 52: 193-196.
54. Lakshmi S, Pillai MR, Nair AS et al (1995a). Cancer of the utrerine cervix: integration of molecular evaluation into management strategy and the concept of biological staging. Curr Sci 68: 45-52.
55. Lakshmi S, Pillai MR, Rajalekshmy TN et al (1995b). Human papillomavirus infection and cervical pre-cancer: implications for management and control. .J Clin Exp Cancer Res 68: 45-52.
56. Lehn H, Villa LL, Marziona F et al (1988). Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. J Gen Virol 69: 187-196.
57. Li N, Karin M (1998). Ionizing radiation and shortwave UV activate NFκB through two distinct mechanisms. Proc Natl Acad Sci U S A 95: 13012-13017.
58. Li W, Thomson CH, O'Brein CJ et al (2003). Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 106: 553-558.
59. Lowy DR, Kimbauer R, Schiller JT (1994). Genital human papillomaviruses. Proc Natl Acad Sci U S A 91: 2436-2440.
60. Marchand LL, Sigfried A, Lum A et al (1998). Association of CYP1A1, GSTM1 and CYP2E1 polymorphisms with lung cancer suggest cell type specifications to tobacco carcinogens. Cancer Res 58: 4858-4863.
61. McMurray HR, Nguyen D, Westbrook TF et al (2001). Biology of human papillomaviruses. Int J Exp Pathol 82: 15-33.
62. Mellin H, Friesland S, Lewensohn R et al (2000). Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89: 300-304.
63. Milde-Langosch K, Reithdorf S, Loning T (2000). Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions: theoretical and practical implications. Virchows Arch 437: 227-233.
64. Miller CS, Johnstone BM (2001). Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91: 622-635.
65. Miller MC, Mohrenweiser HW, Bell DA (2001). Genetic variability in susceptibility and response to toxicants. Toxicol Lett 120: 269-280.
66. Münger K, Phelps WC, Bubb V et al (1989). The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417-4421.
67. Munoz N (2000). Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19: 1-5.
68. Nagpal JK, Patnaik KS, Das BR (2002). Prevalence of high-risk human papillomavirus types and its association with p53 codon 72 polymorphism in tobacco addicted squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 97: 649-653.
69. Nair P, Gangadevi T, Jayaprakash PG et al (1999a). Increased angiogenesis in the uterine cervix associated with human papilloma virus infection. Pathol Res Pract 195: 163-169.
70. Nair P, Nair MK, Jayaprakash PG et al (1999b). Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection. Pathol Oncol Res 5: 95-103.
71. Nair P, Jayaprakash PG, Nair MK et al (2000). Telomerase, p53 and human papilloma virus infection in the uterine cervix. Acta Oncol 39: 65-70.
72. Nair A, Venkatraman M, Malieckal TT et al. (2003). NFκB is constitutively activated in high grade squamous intra-epithelial lesions and squamous cell carcinomas of the uterine cervix. Oncogene 22: 50-58.
73. Nakayama H, Ikebe T, Beppu M et al. (2001). High expression levels of NFκB, IκB kinase alpha and Aκt kinase in squamous cell carcinoma of the oral cavity. Cancer 92: 3037-3044.
74. Nees M, Geoghegan JM, Hymen T et al. (2001). Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NFκB responsive genes in corneal- keratinocyte. J Virol 75: 4283-4296.
75. Newton TR, Patel NM, Bhatt-Nakshatri P et al (1999). Negative regulation of transactivation function but not DNA binding of NF-κB and AP-1 by IκBβ1 in breast cancer cells. J Biol Chem 274: 18827-18835.
76. Nindl I, Rindfleisch K, Lotz B et al (1999). Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intraepithelial neoplasia and cervical cancer. Int J Cancer 82: 203-207.
77. Ondrey FG, Dong G, Sunwoo J et al (1999). Constitutive activation of transcription factors NFκB, AP-1 and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express proinflammatory and proangiogenic cytokines. Mol Carcinogenesis 26: 119-129.
78. Orr JW Jr, Wilson K, Bodiford C et al (1985). Corpus and cervix cancer: a nutritional comparison. Am J Obstet Gynecol 153: 775-779.
79. Pavanello S, Clonfero E (2000). Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat Res 463: 285-308.
80. Paz IB, Cook N, Odom-Maryon T et al (1997). Human Papillomavims in head and neck cancer. An association of HPV 16 with squamous cell carcinomas of Waldeyer's tonsillar ring. Cancer 79: 595-604.
81. Philips AC, Voudsen KH (1999). Human papillomavirus and cancer: the viral transforming genes. Cancer Surv 33: 55-74.
82. Pillai MR, Nair MK (2000). Development of a Condemned Mucosa Syndrome and pathogenesis of human papilloma virus-associated upper aerodigestive tract and uterine cervical tumors. Exp Mol Pathol 69: 233-241.
83. Pillai MR, Rajalekshmy TN, Lakshmi S et al (1993). Clinical significance of human papilloma virus infection in cervical carcinogenisis. In: Bhattathiri VN, Rajan B, Blake P, Nair MK, Eds. Cervical Cancer in Developing Countries. Regional Cancer Centre Publication Division: Trivandrum, pp. 34-38.
84. Pillai MR, Phanidhara A, Kesari AL et al (1999a). Cellular manifestations of human papilloma virus infection in the oral mucosa. J Surg Oncol 71: 10-15.
85. Pillai MR, Ramadas K, Nalinalkumari KR et al (1999b). Cellular manifestations of tumor progression in the oral mucosa: role of human papilloma virus, apoptosis, angiogenesis, proliferation and tumor associated genes p53, Bc12 and Bax. In: Varma AK, Ed. Oral Oncology, Vol. VI. Proceedings of the 6th International Congress on Oral Cancer, New Delhi, 1999. Macmillan India Ltd: New Delhi, pp. 51-54.
86. Pillai MR, Sreevidya S, Pollock BH et al (2002). Polymorphism at codon 72 of p53, human papillomavirus and cervical cancer in South India. J Cancer Res Clin Oncol 128: 627-631.
87. Pillai MR, Chacko P, Kesari AL et al (2003). Expression of folate receptors and heterogenous nuclear ribonucleoprotein-E1 in women with human papillomavirus-mediated transformation of cervical tissue to cancer. J Clin Path 56: 569-574.
88. Piyathilake CJ, Macaluso M, Johanning GL et al (2000). Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res 20(3A): 1751-1757.
89. Potischman N, Brinton LA (1996). Nutrition and cervical neoplasia. Cancer Causes Control 7: 113-126.
90. Prasad AV, Mohan N, Chandrasekar B et al (1994). Induction of NF/κB after low dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Radiat Res 140: 97-104.
91. Rayet B, Gelinas C (1999). Aberrant rel/NF-κB genes and activity in human cancer. Oncogene 18: 6938-6947.
92. Refsum H, Yajnik CS, Gadkari M et al (2001). Hyperhomocysteinemia and elevated methyl malonic acid indicate a high prevalence of cobalamine deficiency in Asian Indians. Am J Clin Nutr 74: 233-241.
93. Rock CL, Lampe JW, Patterson RE (2000). Nutrition, genetics, and risks of cancer. Annu Rev Public Health 21: 47-64.
94. Romney SL, Palan PR, Basu J et al (1995). Nutrient antioxidants in the pathogenesis and prevention of cervical dysplasias and cancer. J Cell Biochem Suppl 23: 96-103.
95. Scheffner M (1998). Ubiquitin, E6-AP and their role in p53 inactivation. Pharmacol Ther 78: 129-139.
96. Sellers WR, Kaelin WG Jr (1997). Role of Rb protein in the pathogenesis of human cancer. J Clin Oncol 15: 3301-3312.
97. Smith EM, Hoffman HT, Summersgill KS et al (1998). Human papillomavirus and risk of oral cancer. Laryngoscope 108: 1098-1103.
98. Smith EM, Ritchie JM, Summersgill KF et al (2004). Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 96: 449-455.
99. Spitkovsky D, Hehner SP, Hofmann TG et al (2002). The Human papilloma virus oncoprotein E7 attenuates NFκB activation by targeting the IκB Kinase complex. J Biol Chem 277: 25576-25582.
100. Sreelekha TT, Ramdas K, Pandey M et al (2001). Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 37: 593-598.
101. Steenbergen RD, Hermsen MA, Walboomers JM et al (1995). Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 55: 5465-5471.
102. Sun XL, Murphy BR, Li QJ et al (1995). Transduction of folate receptor cDNA into cervical carcinoma cells using recombinant adeno-associated virions delays cell proliferation in vitro and in vivo. J Clin Invest 96: 1535-1547.
103. Tait SW, Reid EB, Greaves DR et al (2000). Mechanism of inactivation of NF-κB by a viral homologue of Iκbα. Signal-induced release of NF-κB results in binding of the viral homologue to NF-kappa B. J Biol Chem 275: 34656-34664.
104. Van Antwerp DJ, Martin SJ, Kafri T et al (1996). Suppression of TNF-α-induced apoptosis by NF-κB. Science 274: 787-789.
105. Van Duin M, Snijders PJF, Vossen MTM et al (2000). Analysis of human papillomavirus 16E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenisis. J Gen Virol 81: 317-325.
106. Van Houten VM, Snijders PJ, van den Brekel MW et al (2001). Biological evidence that human papilloma viruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93: 232-235.
107. Velema JP, Ferrera A, Figueroa M et al (2002). Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras. Int J Cancer 97: 536-541.
108. Verreault R, Chu J, Mandelson M et al (1989). A case-control study of diet and cervical cancer. Int J Cancer 43: 1050-1054.
109. Villa LL, Schlegel R (1991). Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region. Virology 181: 374-377.
110. Vokes EE, Weichselbaum RR, Lippman SM et al (1993). Head and neck cancer. N Engl J Med 328: 184-194.
111. Wang CY, Mayo MW, Baldwin AS Jr (1996). TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NFκB. Science 274: 784-787.
112. Wiest T, Schwarz E, Enders C et al (2002). Involvement of intact HPV 16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21: 1510-1517.
113. Wong M, Pagano JS, Schiller JT et al (2002). New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer. J Natl Cancer Inst 94: 1832-1836.
114. Xing D, Tan W, Lin D (2003). Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncol Rep 10: 1615-1623.
115. Xu X, Pang T, Guo Z et al (2001). HPV 16 E6 gene variations in invasive cervical carcinoma and cancer in situ from Russian patients. Br J Cancer 84: 791-795.
116. Yamada T, Manos MM, Peto J et al (1997). Human papilloma type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71: 2463-2472.
117. You M, Ku PT, Hrdlickova R et al (1997). ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein. Mol Cell Biol 17: 7328-7341.
118. Zehbe I, Wilander E, Delius H et al (1998). Human Papillomavirus 16 E6 variants are more prevalent in invasive carcinoma than the prototype. Cancer Res 58: 829-833.
119. Zehbe I, Tachezy R, Mytilineos J et al (2001). Human Papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94: 711-716.
120. Ziegler RG (1986). Epidemiologic studies of vitamins and cancer of the lung, esophagus, and cervix. Adv Exp Med Biol 206: 11-26.
121. Ziegler RG, Jones CJ, Brinton LA et al (1991). Diet and the risk of in situ cervical cancer among white women in the United States. Cancer Causes Control 2: 17-29.
122. Zur Hausen H (1996). Papilloma virus infections - a major cause of human cancers. Biochem Biophys Acta 1288: F55-F78.